Doxazosin for benign prostatic obstruction

Research output: Contribution to journalArticlepeer-review


This is the protocol for a review and there is no abstract. The objectives are as follows: Our goal is to conduct a systematic review and quantitative meta-analysis of the existing evidence from randomized controlled trials to determine the efficacy and safety of the alpha-blocker doxazosin (Cardura, Pfizer Pharmaceuticals) in men with lower urinary tract symptoms compatible with BPO.

Original languageEnglish (US)
Article numberCD003714
JournalCochrane Database of Systematic Reviews
Issue number6
StatePublished - Jun 29 2013

Bibliographical note

Publisher Copyright:
© 2013 The Cochrane Collaboration.


Dive into the research topics of 'Doxazosin for benign prostatic obstruction'. Together they form a unique fingerprint.

Cite this